Trademarkia Logo

Australia

AU$
REMIX THERAPEUTICS
Protected: Registered/protected

Last updated on 12 Dec 2024

Owner Info

Remix Therapeutics Inc.

400 Technology Square

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

2487728 filed on 25 Mar 2024

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

REMIX THERAPEUTICS

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, he Read More

Class [042]
Development of gene-based medicines; gene therapy and modulation research; laboratory research in the field of degrading and enhancing RNA including e Read More

Mark Details


Serial Number

2487728

Registered On

25 Mar 2024

Renewal On

25 Mar 2034

Mark Type

WORD

Priority Claim (Convention Details)


Date

25 Sept 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
12th Dec 2024International Registration in Australia Protected correspondence sent
11th Dec 2024IP Right Registration Published
11th Dec 2024Status change to Registered/Protected
5th Oct 2024Application Accepted correspondence sent
4th Oct 2024IP Right has been Examined
4th Oct 2024IP Right Acceptance Published
4th Oct 2024Status change to Accepted
4th Oct 2024Awaiting examination
4th Oct 2024Examination expedited
3rd Oct 2024IP Right Filed Published